Candida in the lower respiratory tract induces barrier disruption in mice and predicts poor outcomes in mechanically ventilated humans
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2608378123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Nathanial J Tolman und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University …. Hauptthemen laut MEDLINE: Candida albicans, Respiration, Artificial, Candidiasis, Lung Injury. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Candida albicans ( Calb ) in the lower respiratory tract (LRT) is considered a rare cause of pneumonia, yet its frequent recovery from LRT secretions of mechanically ventilated patients associates with poor clinical outcomes. To determine whether Calb contributes to lung injury, we conducted a translational investigation spanning two independent, prospective human cohorts, murine models of lung injury, and in vitro assays. In critically ill patients, Calb was the most abundant fungus in LRT specimens, and its detection associated with increased markers of lung injury, prolonged mechanical ventilation, and increased mortality. In a murine model, intratracheal Calb was sufficient to disrupt the air-blood barrier and recruit neutrophils, effects markedly attenuated with heat-killed Calb . Neutrophil depletion led to uncontrolled fungal growth, systemic dissemination and mortality, with surviving mice exhibiting worsened barrier disruption, demonstrating that neutrophils support pathogen control while lung injury is driven by the live organism. Calb induced lung epithelial cytotoxicity as well as barrier disruption in human alveolar epithelial cells at air liquid interface. Yeast-locked mutants without hyphal morphogenesis demonstrated attenuated barrier disruption in human alveolar cells and diminished lung injury in mice, despite higher fungal burden. In human cohort data, LRT microbiome profiles with high Calb abundance and codominant bacterial pathogens predicted worse mortality, and mouse models confirmed that Calb amplifies lung barrier disruption when followed by Pseudomonas aeruginosa inoculation, an effect requiring hyphal morphogenesis. These findings establish that LRT Calb causes direct air-blood barrier disruption through hyphal morphogenesis and amplifies bacterial lung injury, challenging the prevailing view of Candida as an innocent respiratory bystander.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, PA 15213.
- Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794.
- Acute Lung Injury and Infection Center, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213.
- Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA 98195.
- Hospital and Specialty Service, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108.
- Translational Immunology, Benaroya Research Institute, Seattle, WA 98101.
ORCID-Profile: Nathanial J Tolman, Wonseok Choi, Mark E Snyder, Lokesh Sharma, Shulin Qin, Carmen Mikacenic, Jonathan K Alder, Yingze Zhang, Panayiotis V Benos, Jessica Bon, William Bain, Georgios D Kitsios
Förderung
- NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- United States Department of Veterans Affairs Biomedical Laboratory R&D Services
- HHS | NIH (NIH)
- BLRD VA
Zitieren
APA
Tolman, N. J., Choi, W., Coulter, R., Snyder, M. E., Sharma, L., Qin, S., Morrell, E. D., Mikacenic, C., Alder, J. K., Wang, X., Tabary, M., Zhang, Y., Inman, K., Britton, N., Methe, B., Benos, P. V., Bon, J., Robinson, K., Dela Cruz, C., …, & Kitsios, G. D. (2026). Candida in the lower respiratory tract induces barrier disruption in mice and predicts poor outcomes in mechanically ventilated humans. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2608378123
Vancouver
Tolman NJ, Choi W, Coulter R, Snyder ME, Sharma L, Qin S, et al. Candida in the lower respiratory tract induces barrier disruption in mice and predicts poor outcomes in mechanically ventilated humans. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2608378123
BibTeX
@article{Tolman2026,
author = {Tolman, Nathanial J and Choi, Wonseok and Coulter, Riley and Snyder, Mark E and Sharma, Lokesh and Qin, Shulin and Morrell, Eric D and Mikacenic, Carmen and Alder, Jonathan K and Wang, Xiaohong and Tabary, Mohammadreza and Zhang, Yingze and Inman, Kyle and Britton, Noel and Methe, Barbara and Benos, Panayiotis V and Bon, Jessica and Robinson, Keven and Dela Cruz, Charles and Nguyen, M Hong and Morris, Alison and Biswas, Partha S and Bain, William and Kitsios, Georgios D},
title = {Candida in the lower respiratory tract induces barrier disruption in mice and predicts poor outcomes in mechanically ventilated humans},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2608378123}
}
EUVIMED